Current clinical understanding and effectiveness of portopulmonary hypertension treatment

Portopulmonary hypertension (PoPH) is a rare subtype of Group 1 pulmonary arterial hypertension (PAH) with a poor prognosis. According to the most up-to-date definition, PoPH is characterized by a mean pulmonary arterial pressure (PAP) of >20 mmHg at rest, a pulmonary artery wedge pressure of ≤15...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Yuichi Tamura, Yudai Tamura, Yu Taniguchi, Masanori Atsukawa
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Frontiers Media S.A. 2023-04-01
סדרה:	Frontiers in Medicine
נושאים:	portopulmonary hypertension treatment endothelin receptor antagonist liver transplantation pulmonary arterial hypertension screening
גישה מקוונת:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1142836/full
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!